title: Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions".
authors.forename: Roberto
authors.initials: R
authors.lastname: Manfredini
authors.forename: Benedetta
authors.initials: B
authors.lastname: Boari
authors.forename: Massimo
authors.initials: M
authors.lastname: Gallerani
authors.forename: Francesco
authors.initials: F
authors.lastname: Portaluppi
authors.forename: Rajendra H
authors.initials: RH
authors.lastname: Mehta
mesh_terms: D002406:Catheterization, Peripheral; D006801:Humans; D010960:Plasminogen Activators / Q000191:economics / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000191:economics / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome; D014568:Urokinase-Type Plasminogen Activator / Q000191:economics / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy / Q000191:economics
chemical_list: D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator